Results 71 to 80 of about 1,457,300 (387)

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui   +6 more
wiley   +1 more source

Strengthening immunology literacy: an adaptable curricular framework for enhancing undergraduate immunology education

open access: yesFrontiers in Education
The rapidly expanding knowledge base in immunology and its increasing significance in multiple research areas and healthcare underscore the need for more comprehensive undergraduate curricula that allow students to engage deeply with immunology-based ...
Chad R. Sethman, Kelly J. R. Collins
doaj   +1 more source

Transplantation Immunology

open access: yesPediatric Clinics of North America, 1994
A major function of the immune response is the discrimination of self from nonself. It is this response that must be overcome in transplant rejection. Progress in understanding these basic immune mechanisms has helped to improve clinical outcome and lays the foundation for a new generation of therapies.
A M, Krensky, C, Clayberger
openaire   +2 more sources

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

open access: yesMolecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad   +12 more
wiley   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

open access: yesMolecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken   +3 more
wiley   +1 more source

The Function of the TGFβ Signaling Pathway in Connective Tissue Diseases: From Biology to Clinical Application

open access: yesJournal of Inflammation Research
Simin Yuan,1 Wen Zhu,2 Yue Wang,1,2 Lili Yu1,3,4 1Faculty of Chinese Medicine, Macau University of Science and Technology, Macau, People’s Republic of China; 2Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of ...
Yuan S, Zhu W, Wang Y, Yu L
doaj  

VETERINARY IMMUNOLOGY

open access: yesМедицинская иммунология, 2015
.
Article Editorial
doaj   +1 more source

Immunology of Wound Healing

open access: yesCurrent Dermatology Reports, 2018
Purpose of ReviewChronic wounds are a tremendous burden on the healthcare system and lead to significant patient morbidity and mortality. Normal cutaneous wound healing occurs through an intricate and delicate interplay between the immune system ...
S. Ellis, Elaine J. Lin, D. Tartar
semanticscholar   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy